Have a personal or library account? Click to login
Case series of idiopathic obliterative bronchiolitis in adults: Insights into a rare condition Cover

Case series of idiopathic obliterative bronchiolitis in adults: Insights into a rare condition

Open Access
|Feb 2026

Figures & Tables

Figure 1.

HRCT - Bilateral diffused mosaic attenuation patterns representing air trapping and normal parenchyma more pronounced on expiration (B) than on inspiration (A).
HRCT - Bilateral diffused mosaic attenuation patterns representing air trapping and normal parenchyma more pronounced on expiration (B) than on inspiration (A).

Figure 2.

HRCT - Bilateral diffused mosaic attenuation patterns representing air trapping and bronchiectasis.
HRCT - Bilateral diffused mosaic attenuation patterns representing air trapping and bronchiectasis.

Figure 3A.

(A) High-resolution chest CT demonstrated bilateral areas of increased lucency, predominantly in the basal regions. (B) Lung-biopsy specimens of a bronchiole (haematoxylin-eosin staining) - bronchiolar wall is thickened by fibrosis (), lymphocytic inflammation () and anthracitic pigment deposits (). CT, computer tomography.
(A) High-resolution chest CT demonstrated bilateral areas of increased lucency, predominantly in the basal regions. (B) Lung-biopsy specimens of a bronchiole (haematoxylin-eosin staining) - bronchiolar wall is thickened by fibrosis (), lymphocytic inflammation () and anthracitic pigment deposits (). CT, computer tomography.

Summary of diagnostic investigations_

Patient 1Patient 2Patient 3
HR–CTMosaic attenuationAir trappingMosaic attenuationAir trappingIncreased lucency, predominantly in the basal regions
BALMacrophages – 58,85%Lymphocytes – 29,3%Granulocytes – 11,6%Neutrophil – 11,1%Eosinophils – 0,5%Epithelial cells – 29%Tumor cells – NoNoNo
Lung BiopsyNoNoYes

Main characteristics of the 3 patients

Patient 1Patient 2Patient 3
Age/sex68 / F33 / M30 / M
SmokingFormer smoker 20 PYNoNo
ExposureNoNoNo
Associated diseaseHypertension, DyslipidemiaLichen planusNo
ClinicalDyspnea Dry coughDyspnea intermittent productive cough.Dyspnea
Spirometry/FEV 1 (l/%)Severe obstruction/0,74 (40%)Severe fixed obstruction/0,58 (14,1%)Severe obstruction/1,8 (42%)
FEV1/FVC (%)45%32,89%58,13%
FVC (l/%)1,64 (74%)1,64 (33,5%)3,12 (61%)
TLC(l/%)MD8,85 (128,3%)8,11 (114%)
RV(l/%)MD7,12 (398,2%)4,98 (281%)
DLCO (%)65%32,4%77%
6MWTsignificant oxygen desaturation – final SpO2 90%significant oxygen desaturation - final SpO2 88% after 2 minutessignificant oxygen desaturation - final SpO2 88%

Evolution of the symptoms, respiratory function and 6MWT after one month of treatment

Patient 1- after 1 monthPatient 2 – after 2 monthsPatient 3 – after one year
ClinicalImprovement of exercitional dyspnea, Cough remissionDyspnea intermittent productive cough.Improvement of exercitional dyspnea
Spirometry/FEV1 (l)Improved 0,85lNo improvement 0,55lNo improvement 1,51
FEV1/FVC (%)No improvement 42,9%No improvement 29,94%No improvement 50,38%
FVC (l)Improved 1,97No improvement 1,64No improvement 2,99
TLC(l)MDImproved 7,91No improvement 8
RV(l)MDImproved 5,53lNo improvement 5
DLCO (%)Improved 71%No improvement 30,2%No improvement 75%
TM6MImproved – no desaturationWorseImproved – important desaturation but with final SpO2>90%
DOI: https://doi.org/10.2478/pneum-2025-0038 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 136 - 142
Published on: Feb 16, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2026 Ştefania-Florina Oprea, Stefan Dumitrache-Rujinski, Ionela Belaconi, Diana Leonte, Alina-Valentina Ďobrotă, Claudia-Lucia Toma, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.